Diverse actions of retinoid receptors in cancer prevention and treatment

Differentiation

Volumn 75, Issue 9, 2007, Pages 853-870

  Mongan, Nigel P ^a   Gudas, Lorraine J ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Cell cycle; Cyp26; Differentiation; LRAT; RALDH2; RAR ; Retinoic acid receptor; Retinol; Review; sRBP (RBP4); Stem cell

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; ALITRETINOIN; BUTYRIC ACID; CYTOCHROME P450; CYTOCHROME P450 26A1; DNA METHYLTRANSFERASE INHIBITOR; DRUG METABOLITE; HISTONE DEACETYLASE INHIBITOR; HYBRID PROTEIN; ISOTRETINOIN; LECITHIN RETINOL ACYLTRANSFERASE; RETINAL DEHYDROGENASE; RETINAL DEHYDROGENASE 2; RETINOIC ACID; RETINOIC ACID RECEPTOR; RETINOIC ACID RECEPTOR ALPHA; RETINOIC ACID RECEPTOR BETA; RETINOIC ACID RECEPTOR GAMMA; RETINOID; REXINOID RECEPTOR ALPHA; REXINOID RECEPTOR BETA; REXINOID RECEPTOR GAMMA; UNCLASSIFIED DRUG; VALPROIC ACID;

CANCER; CANCER CELL; CANCER INHIBITION; CANCER PREVENTION; CANCER RESISTANCE; CARCINOMA; CELL CYCLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL TYPE; DIET THERAPY; DRUG ACTIVITY; DRUG EFFICACY; DRUG RECEPTOR BINDING; HUMAN; MOLECULAR MECHANICS; MUTATION; NONHUMAN; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; VITAMIN METABOLISM;

EID: 36048985726     PISSN: 03014681     EISSN: 14320436     Source Type: Journal    
DOI: 10.1111/j.1432-0436.2007.00206.x     Document Type: Review

References (245)

1. Ahuja, H.S., Szanto, A., Nagy, L. Davies, P.J. (2003) The retinoid X receptor and its ligands: versatile regulators of metabolic function, cell differentiation and cell death. J Biol Regul Homeost Agents 17 : 29 45.
2. Al-Hajj, M. Clarke, M.F. (2004) Self-renewal and solid tumor stem cells. Oncogene 23 : 7274 7282.
3. Al-Hajj, M., Wicha, M.S., Benito-Hernandez, A., Morrison, S.J. Clarke, M.F. (2003) Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 100 : 3983 3988.
4. Allenby, G., Bocquel, M.T., Saunders, M., Kazmer, S., Speck, J., Rosenberger, M., Lovey, A., Kastner, P., Grippo, J.F., Chambon, P. Levin, A.A. (1993) Retinoic acid receptors and retinoid X receptors: interactions with endogenous retinoic acids. Proc Natl Acad Sci USA 90 : 30 34.
5. Altucci, L., Rossin, A., Raffelsberger, W., Reitmair, A., Chomienne, C. Gronemeyer, H. (2001) Retinoic acid-induced apoptosis in leukemia cells is mediated by paracrine action of tumor-selective death ligand TRAIL. Nat Med 7 : 680 686.
6. Altucci, L., Wilhelm, E. Gronemeyer, H. (2004) Leukemia: beneficial actions of retinoids and rexinoids. Int J Biochem Cell Biol 36 : 178 182.
7. Avis, I., Mathias, A., Unsworth, E.J., Miller, M.J., Cuttitta, F., Mulshine, J.L. Jakowlew, S.B. (1995) Analysis of small cell lung cancer cell growth inhibition by 13-cis-retinoic acid: importance of bioavailability. Cell Growth Differ 6 : 485 492.
8. Baldassarre, G., Boccia, A., Bruni, P., Sandomenico, C., Barone, M.V., Pepe, S., Angrisano, T., Belletti, B., Motti, M.L., Fusco, A. Viglietto, G. (2000) Retinoic acid induces neuronal differentiation of embryonal carcinoma cells by reducing proteasome-dependent proteolysis of the cyclin-dependent inhibitor p27. Cell Growth Differ 11 : 517 526.
9. Balic, M., Lin, H., Young, L., Hawes, D., Giuliano, A., McNamara, G., Datar, R.H. Cote, R.J. (2006) Most early disseminated cancer cells detected in bone marrow of breast cancer patients have a putative breast cancer stem cell phenotype. Clin Cancer Res 12 : 5615 5621.
10. Bastien, J. Rochette-Egly, C. (2004) Nuclear retinoid receptors and the transcription of retinoid-target genes. Gene 328 : 1 16.
11. Bean, G.R., Scott, V., Yee, L., Ratliff-Daniel, B., Troch, M.M., Seo, P., Bowie, M.L., Marcom, P.K., Slade, J., Kimler, B.F., Fabian, C.J., Zalles, C.M., Broadwater, G., Baker, J.C. Jr., Wilke, L.G. Seewaldt, V.L. (2005) Retinoic acid receptor-beta2 promoter methylation in random periareolar fine needle aspiration. Cancer Epidemiol Biomarkers Prev 14 : 790 798.
12. Benbrook, D., Lernhardt, E. Pfahl, M. (1988) A new retinoic acid receptor identified from a hepatocellular carcinoma. Nature 333 : 669 672.
13. Bertram, J.S. Vine, A.L. (2005) Cancer prevention by retinoids and carotenoids: independent action on a common target. Biochim Biophys Acta 1740 : 170 178.
14. Biesalski, H.K. Nohr, D. (2004) New aspects in vitamin a metabolism: the role of retinyl esters as systemic and local sources for retinol in mucous epithelia. J Nutrit 134 : 3453S 3457S.
15. Bistulfi, G., Pozzi, S., Ren, M., Rossetti, S. Sacchi, N. (2006) A repressive epigenetic domino effect confers susceptibility to breast epithelial cell transformation: implications for predicting breast cancer risk. Cancer Res 66 : 10308 10314.
16. Bjelakovic, G., Nikolova, D., Gluud, L.L., Simonetti, R.G. Gluud, C. (2007) Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis. JAMA 297 : 842 857.
17. Blanco, J.C., Minucci, S., Lu, J., Yang, X.J., Walker, K.K., Chen, H., Evans, R.M., Nakatani, Y. Ozato, K. (1998) The histone acetylase PCAF is a nuclear receptor coactivator. Genes Dev 12 : 1638 1651.
18. Blomhoff, R. Blomhoff, H.K. (2006) Overview of retinoid metabolism and function. J Neurobiol 66 : 606 630.
19. Bocchia, M., Xu, Q., Wesley, U., Xu, Y., Korontsvit, T., Loganzo, F., Albino, A.P. Scheinberg, D.A. (1997) Modulation of p53, WAF1/p21 and BCL-2 expression during retinoic acid-induced differentiation of NB4 promyelocytic cells. Leuk Res 21 : 439 447.
20. Bollag, W. (1972) Prophylaxis of chemical induced benign and malignant epithelial tumors by vitamin A (retinoic acid). Eur J Cancer 8 : 583 589.
21. Bommer, M., Benecke, A., Gronemeyer, H. Rochette-Egly, C. (2002) TIF2 mediates the synergy between RARalpha 1 activation functions AF-1 and AF-2. J Biol Chem 277 : 37961 37966.
22. Boorjian, S., Scherr, D.S., Mongan, N.P., Zhuang, Y., Nanus, D.M. Gudas, L.J. (2005) Retinoid receptor mRNA expression profiles in human bladder cancer specimens. Int J Oncol 26 : 1041 1048.
23. Boorjian, S., Tickoo, S.K., Mongan, N.P., Yu, H., Bok, D., Rando, R.R., Nanus, D.M., Scherr, D.S. Gudas, L.J. (2004) Reduced lecithin: retinol acyltransferase expression correlates with increased pathologic tumor stage in bladder cancer. Clin Cancer Res 10 : 3429 3437.
24. Boorjian, S.A., Milowski, M.I., Kaplan, J., Albert, M., Cobham, M., Coll, D.M., Mongan, N.P., Shelton, G., Petrylak, D., Gudas, L.J. Nanus, D.M. (2007) Phase I/II trial of interferon alpha2b and liposome-encapsulated all-trans retinoic acid in the treatment of patients with advanced renal cell carcinoma. J Immunother (in press).
25. Borriello, A., Cucciolla, V., Criscuolo, M., Indaco, S., Oliva, A., Giovane, A., Bencivenga, D., Iolascon, A., Zappia, V. Della Ragione, F. (2006) Retinoic acid induces p27Kip1 nuclear accumulation by modulating its phosphorylation. Cancer Res 66 : 4240 4248.
26. Boyle, J.O., Langenfeld, J., Lonardo, F., Sekula, D., Reczek, P., Rusch, V., Dawson, M.I. Dmitrovsky, E. (1999) Cyclin D1 proteolysis: a retinoid chemoprevention signal in normal, immortalized, and transformed human bronchial epithelial cells. J Natl Cancer Inst 91 : 373 379.
27. Bracken, A.P., Dietrich, N., Pasini, D., Hansen, K.H. Helin, K. (2006) Genome-wide mapping of Polycomb target genes unravels their roles in cell fate transitions. Genes Dev 20 : 1123 1136.
28. Brand, N., Petkovich, M., Krust, A., Chambon, P., de The, H., Marchio, A., Tiollais, P. Dejean, A. (1988) Identification of a second human retinoic acid receptor. Nature 332 : 850 853.
29. Brown, K., Chen, Y., Underhill, T.M., Mymryk, J.S. Torchia, J. (2003) The coactivator p/CIP/SRC-3 facilitates retinoic acid receptor signaling via recruitment of GCN5. J Biol Chem 278 : 39402 39412.
30. Bug, G., Ritter, M., Wassmann, B., Schoch, C., Heinzel, T., Schwarz, K., Romanski, A., Kramer, O.H., Kampfmann, M., Hoelzer, D., Neubauer, A., Ruthardt, M. Ottmann, O.G. (2005) Clinical trial of valproic acid and all-trans retinoic acid in patients with poor-risk acute myeloid leukemia. Cancer 104 : 2717 2725.
31. Buletic, Z., Soprano, K.J. Soprano, D.R. (2006) Retinoid targets for the treatment of cancer. Crit Rev Eukaryot Gene Expr 16 : 193 210.
32. Cameron, E.E., Bachman, K.E., Myohanen, S., Herman, J.G. Baylin, S.B. (1999) Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer. Nature Gen 21 : 103 107.
33. Chambers, I., Colby, D., Robertson, M., Nichols, J., Lee, S., Tweedie, S. Smith, A. (2003) Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells. Cell 113 : 643 655.
34. Chen, A.C. Gudas, L.J. (1996) An analysis of retinoic acid-induced gene expression and metabolism in AB1 embryonic stem cells. J Biol Chem 271 : 14971 14980.
35. Chen, C.F., Goyette, P. Lohnes, D. (2004) RARgamma acts as a tumor suppressor in mouse keratinocytes. Oncogene 23 : 5350 5359.
36. Chen, Q. Ross, A.C. (2004) Retinoic acid regulates cell cycle progression and cell differentiation in human monocytic THP-1 cells. Exp Cell Res 297 : 68 81.
37. Cheung, B.B., Bell, J., Raif, A., Bohlken, A., Yan, J., Roediger, B., Poljak, A., Smith, S., Lee, M., Thomas, W.D., Kavallaris, M., Norris, M., Haber, M., Liu, H.L., Zajchowski, D. Marshall, G.M. (2006) The estrogen-responsive B box protein is a novel regulator of the retinoid signal. J Biol Chem 281 : 18246 18256.
38. Chopra, D.P. Wilkoff, L.J. (1977) Reversal by vitamin A analogues (retinoids) of hyperplasia induced by N-methyl-N′-nitro-N-nitrosoguanidine in mouse prostate organ cultures. J Natl Cancer Inst 58 : 923 930.
39. Chopra, D.P. Wilkoff, L.J. (1979) Activity of retinoids against benzo(A)pyrene induced hyperplasia in mouse prostate organ cultures. Eur J Cancer 15 : 1417 1423.
40. Chuang, K.H., Lee, Y.F., Lin, W.J., Chu, C.Y., Altuwaijri, S., Wan, Y.J. Chang, C. (2005) 9-cis-retinoic acid inhibits androgen receptor activity through activation of retinoid X receptor. Mol Endocrinol 19 : 1200 1212.
41. Cimino, G., Lo-Coco, F., Fenu, S., Travaglini, L., Finolezzi, E., Mancini, M., Nanni, M., Careddu, A., Fazi, F., Padula, F., Fiorini, R., Aloe Spiriti, M.A., Petti, M.C., Venditti, A., Amadori, S., Mandelli, F., Pelicci, P.G. Nervi, C. (2006) Sequential valproic acid/all-trans retinoic acid treatment reprograms differentiation in refractory and high-risk acute myeloid leukemia. Cancer Res 66 : 8903 8911.
42. Clarke, N., Jimenez-Lara, A.M., Voltz, E. Gronemeyer, H. (2004) Tumor suppressor IRF-1 mediates retinoid and interferon anticancer signaling to death ligand TRAIL. EMBO J 23 : 3051 3060.
43. Cras, A., Darsin-Bettinger, D., Balitrand, N., Cassinat, B., Soulie, A., Toubert, M.E., Delva, L. Chomienne, C. (2007) Epigenetic patterns of the retinoic acid receptor beta(2) promoter in retinoic acid-resistant thyroid cancer cells. Oncogene 26 : 4218 4224.
44. Dahl, A.R., Grossi, I.M., Houchens, D.P., Scovell, L.J., Placke, M.E., Imondi, A.R., Stoner, G.D., De Luca, L.M., Wang, D. Mulshine, J.L. (2000) Inhaled isotretinoin (13-cis retinoic acid) is an effective lung cancer chemopreventive agent in A/J mice at low doses: a pilot study. Clin Cancer Res 6 : 3015 3024.
45. Dawson, M.I. (2004) Synthetic retinoids and their nuclear receptors. Curr Med Chem Anticancer Agents 4 : 199 230.
46. de The, H., Vivanco-Ruiz, M.M., Tiollais, P., Stunnenberg, H. Dejean, A. (1990) Identification of a retinoic acid responsive element in the retinoic acid receptor beta gene. Nature 343 : 177 180.
47. Dean, M. (2006) Cancer stem cells: redefining the paradigm of cancer treatment strategies. Mol Interv 6 : 140 148.
48. Delva, L., Bastie, J.N., Rochette-Egly, C., Kraiba, R., Balitrand, N., Despouy, G., Chambon, P. Chomienne, C. (1999) Physical and functional interactions between cellular retinoic acid binding protein II and the retinoic acid-dependent nuclear complex. Mol Cell Biol 19 : 7158 7167.
49. Depoix, C., Delmotte, M.H., Formstecher, P. Lefebvre, P. (2001) Control of retinoic acid receptor heterodimerization by ligand-induced structural transitions. A novel mechanism of action for retinoid antagonists. J Biol Chem 276 : 9452 9459.
50. Despouy, G., Bastie, J.N., Deshaies, S., Balitrand, N., Mazharian, A., Rochette-Egly, C., Chomienne, C. Delva, L. (2003) Cyclin D3 is a cofactor of retinoic acid receptors, modulating their activity in the presence of cellular retinoic acid-binding protein II. J Biol Chem 278 : 6355 6362.
51. Di Croce, L. (2005) Chromatin modifying activity of leukaemia associated fusion proteins. Hum Mol Genet 14 (Spec No. 1) : R77 R84.
52. Di Croce, L., Raker, V.A., Corsaro, M., Fazi, F., Fanelli, M., Faretta, M., Fuks, F., Lo Coco, F., Kouzarides, T., Nervi, C., Minucci, S. Pelicci, P.G. (2002) Methyltransferase recruitment and DNA hypermethylation of target promoters by an oncogenic transcription factor. Science 295 : 1079 1082.
53. Dietze, E.C., Troch, M.M., Bowie, M.L., Yee, L., Bean, G.R. Seewaldt, V.L. (2003) CBP/p300 induction is required for retinoic acid sensitivity in human mammary cells. Biochem Biophys Res Commun 302 : 841 848.
54. Dillard, A.C. Lane, M.A. (2007) Retinol decreases beta-catenin protein levels in retinoic acid-resistant colon cancer cell lines. Mol Carcinog 46 : 315 329.
55. Dilworth, F.J., Fromental-Ramain, C., Yamamoto, K. Chambon, P. (2000) ATP-driven chromatin remodeling activity and histone acetyltransferases act sequentially during transactivation by RAR/RXR In vitro. Mol Cell 6 : 1049 1058.
56. Dimberg, A., Bahram, F., Karlberg, I., Larsson, L.G., Nilsson, K. Oberg, F. (2002) Retinoic acid-induced cell cycle arrest of human myeloid cell lines is associated with sequential down-regulation of c-Myc and cyclin E and posttranscriptional up-regulation of p27(Kip1). Blood 99 : 2199 2206.
57. Dimberg, A., Karlberg, I., Nilsson, K. Oberg, F. (2003) Ser727/Tyr701-phosphorylated Stat1 is required for the regulation of c-Myc, cyclins, and p27Kip1 associated with ATRA-induced G0/G1 arrest of U-937 cells. Blood 102 : 254 261.
58. Dimberg, A. Oberg, F. (2003) Retinoic acid-induced cell cycle arrest of human myeloid cell lines. Leuk Lymphoma 44 : 1641 1650.
59. Eisinger, A.L., Nadauld, L.D., Shelton, D.N., Peterson, P.W., Phelps, R.A., Chidester, S., Stafforini, D.M., Prescott, S.M. Jones, D.A. (2006) The adenomatous polyposis coli tumor suppressor gene regulates expression of cyclooxygenase-2 by a mechanism that involves retinoic acid. J Biol Chem 281 : 20474 20482.
60. Ekberg, J., Brunhoff, C., Jaras, M., Fan, X., Landberg, G. Persson, J.L. (2006) Increased expression of cyclin A1 protein is associated with all-trans retinoic acid-induced apoptosis. Int J Biochem Cell Biol 38 : 1330 1339.
61. Epping, M.T., Wang, L., Edel, M.J., Carlee, L., Hernandez, M. Bernards, R. (2005) The human tumor antigen PRAME is a dominant repressor of retinoic acid receptor signaling. Cell 122 : 835 847.
62. Estey, E.H., Giles, F.J., Kantarjian, H., O'Brien, S., Cortes, J., Freireich, E.J., Lopez-Berestein, G. Keating, M. (1999) Molecular remissions induced by liposomal-encapsulated all-trans retinoic acid in newly diagnosed acute promyelocytic leukemia. Blood 94 : 2230 2235.
63. Faria, T.N., LaRosa, G.J., Wilen, E., Liao, J. Gudas, L.J. (1998) Characterization of genes which exhibit reduced expression during the retinoic acid-induced differentiation of F9 teratocarcinoma cells: involvement of cyclin D3 in RA-mediated growth arrest. Mol Cell Endocrinol 143 : 155 166.
64. Faria, T.N., Mendelsohn, C., Chambon, P. Gudas, L.J. (1999) The targeted disruption of both alleles of RARbeta(2) in F9 cells results in the loss of retinoic acid-associated growth arrest. J Biol Chem 274 : 26783 26788.
65. Farias, E.F., Arapshian, A., Bleiweiss, I.J., Waxman, S., Zelent, A. Mira, Y.L.R. (2002) Retinoic acid receptor alpha2 is a growth suppressor epigenetically silenced in MCF-7 human breast cancer cells. Cell Growth Differ 13 : 335 341.
66. Fazi, F., Zardo, G., Gelmetti, V., Travaglini, L., Ciolfi, A., Di Croce, L., Rosa, A., Bozzoni, I., Grignani, F., Lo-Coco, F., Pelicci, P.G. Nervi, C. (2007) Heterochromatic gene repression of the retinoic acid pathway in acute myeloid leukemia. Blood 109 : 4432 4440.
67. Fenaux, P., Wang, Z.Z. Degos, L. (2007) Treatment of acute promyelocytic leukemia by retinoids. Curr Top Microbiol Immunol 313 : 101 128.
68. Flajollet, S., Lefebvre, B., Rachez, C. Lefebvre, P. (2006) Distinct roles of the steroid receptor coactivator 1 and of MED1 in retinoid-induced transcription and cellular differentiation. J Biol Chem 281 : 20338 20348.
69. Flamant, F., Baxter, J.D., Forrest, D., Refetoff, S., Samuels, H., Scanlan, T.S., Vennstrom, B. Samarut, J. (2006) International Union of Pharmacology. LIX. The pharmacology and classification of the nuclear receptor superfamily: thyroid hormone receptors. Pharmacol Rev 58 : 705 711.
70. Freemantle, S.J., Spinella, M.J. Dmitrovsky, E. (2003) Retinoids in cancer therapy and chemoprevention: promise meets resistance. Oncogene 22 : 7305 7315.
71. Gaillard, E., Bruck, N., Brelivet, Y., Bour, G., Lalevee, S., Bauer, A., Poch, O., Moras, D. Rochette-Egly, C. (2006) Phosphorylation by PKA potentiates retinoic acid receptor alpha activity by means of increasing interaction with and phosphorylation by cyclin H/cdk7. Proc Natl Acad Sci USA 103 : 9548 9553.
72. Garcia-Manero, G., Kantarjian, H.M., Sanchez-Gonzalez, B., Yang, H., Rosner, G., Verstovsek, S., Rytting, M., Wierda, W.G., Ravandi, F., Koller, C., Xiao, L., Faderl, S., Estrov, Z., Cortes, J., O'Brien, S., Estey, E., Bueso-Ramos, C., Fiorentino, J., Jabbour, E. Issa, J.P. (2006) Phase 1/2 study of the combination of 5-aza-2′-deoxycytidine with valproic acid in patients with leukemia. Blood 108 : 3271 3279.
73. Gartel, A.L. Radhakrishnan, S.K. (2005) Lost in transcription: p21 repression, mechanisms, and consequences. Cancer Res 65 : 3980 3985.
74. Gebert, J.F., Moghal, N., Frangioni, J.V., Sugarbaker, D.J. Neel, B.G. (1991) High frequency of retinoic acid receptor beta abnormalities in human lung cancer. Oncogene 6 : 1859 1868.
75. Germain, P., Iyer, J., Zechel, C. Gronemeyer, H. (2002) Co-regulator recruitment and the mechanism of retinoic acid receptor synergy. Nature 415 : 187 192.
76. Giacinti, C. Giordano, A. (2006) RB and cell cycle progression. Oncogene 25 : 5220 5227.
77. Giguere, V., Ong, E.S., Segui, P. Evans, R.M. (1987) Identification of a receptor for the morphogen retinoic acid. Nature 330 : 624 629.
78. 2, and Cyp26A1 in F9 Embryonal Carcinoma Cells. (Submitted).
79. Glozak, M.A. Rogers, M.B. (2001) Retinoic acid- and bone morphogenetic protein 4-induced apoptosis in P19 embryonal carcinoma cells requires p27. Exp Cell Res 268 : 128 138.
80. Goldberg, J.S., Vargas, M., Rosmarin, A.S., Milowsky, M.I., Papanicoloau, N., Gudas, L.J., Shelton, G., Feit, K., Petrylak, D. Nanus, D.M. (2002) Phase I trial of interferon alpha2b and liposome-encapsulated all-trans retinoic acid in the treatment of patients with advanced renal cell carcinoma. Cancer 95 : 1220 1227.
81. Gregorieff, A. Clevers, H. (2005) Wnt signaling in the intestinal epithelium: from endoderm to cancer. Genes Dev 19 : 877 890.
82. Grote, H.J., Schmiemann, V., Geddert, H., Rohr, U.P., Kappes, R., Gabbert, H.E. Bocking, A. (2005) Aberrant promoter methylation of p16(INK4a), RARB2 and SEMA3B in bronchial aspirates from patients with suspected lung cancer. Int J Cancer 116 : 720 725.
83. Grunt, T.W., Puckmair, K., Tomek, K., Kainz, B. Gaiger, A. (2005) An EGF receptor inhibitor induces RAR-beta expression in breast and ovarian cancer cells. Biochem Biophys Res Commun 329 : 1253 1259.
84. Grunt, T.W., Tomek, K., Wagner, R., Puckmair, K., Kainz, B., Runzler, D., Gaiger, A., Kohler, G. Zielinski, C.C. (2007) Upregulation of retinoic acid receptor-beta by the epidermal growth factor-receptor inhibitor PD153035 is not mediated by blockade of ErbB pathways. J Cell Physiol 211 : 803 815.
85. Guo, X., Knudsen, B.S., Peehl, D.M., Ruiz, A., Bok, D., Rando, R.R., Rhim, J.S., Nanus, D.M. Gudas, L.J. (2002) Retinol metabolism and lecithin: retinol acyltransferase levels are reduced in cultured human prostate cancer cells and tissue specimens. Cancer Res 62 : 1654 1661.
86. Guo, X., Nanus, D.M., Ruiz, A., Rando, R.R., Bok, D. Gudas, L.J. (2001) Reduced levels of retinyl esters and vitamin A in human renal cancers. Cancer Res 61 : 2774 2781.
87. Guo, X., Ruiz, A., Rando, R.R., Bok, D. Gudas, L.J. (2000) Esterification of all-trans-retinol in normal human epithelial cell strains and carcinoma lines from oral cavity, skin and breast: reduced expression of lecithin: retinol acyltransferase in carcinoma lines. Carcinogenesis 21 : 1925 1933.
88. Hayashi, K., Yokozaki, H., Goodison, S., Oue, N., Suzuki, T., Lotan, R., Yasui, W. Tahara, E. (2001) Inactivation of retinoic acid receptor beta by promoter CpG hypermethylation in gastric cancer. Differentiation 68 : 13 21.
89. Hemmati, H.D., Nakano, I., Lazareff, J.A., Masterman-Smith, M., Geschwind, D.H., Bronner-Fraser, M. Kornblum, H.I. (2003) Cancerous stem cells can arise from pediatric brain tumors. Proc Natl Acad Sci USA 100 : 15178 15183.
90. Hermanson, O., Jepsen, K. Rosenfeld, M.G. (2002) N-CoR controls differentiation of neural stem cells into astrocytes. Nature 419 : 934 939.
91. Heyman, R.A., Mangelsdorf, D.J., Dyck, J.A., Stein, R.B., Eichele, G., Evans, R.M. Thaller, C. (1992) 9-cis retinoic acid is a high affinity ligand for the retinoid X receptor. Cell 68 : 397 406.
92. Hong, H., Kohli, K., Garabedian, M.J. Stallcup, M.R. (1997) GRIP1, a transcriptional coactivator for the AF-2 transactivation domain of steroid, thyroid, retinoid, and vitamin D receptors. Mol Cell Biol 17 : 2735 2744.
93. Hoque, M.O., Begum, S., Topaloglu, O., Jeronimo, C., Mambo, E., Westra, W.H., Califano, J.A. Sidransky, D. (2004) Quantitative detection of promoter hypermethylation of multiple genes in the tumor, urine, and serum DNA of patients with renal cancer. Cancer Res 64 : 5511 5517.
94. Hsu, S.L., Hsu, J.W., Liu, M.C., Chen, L.Y. Chang, C.D. (2000) Retinoic acid-mediated G1 arrest is associated with induction of p27(Kip1) and inhibition of cyclin-dependent kinase 3 in human lung squamous carcinoma CH27 cells. Exp Cell Res 258 : 322 331.
95. Hu, L., Crowe, D.L., Rheinwald, J.G., Chambon, P. Gudas, L.J. (1991) Abnormal expression of retinoic acid receptors and keratin 19 by human oral and epidermal squamous cell carcinoma cell lines. Cancer Res 51 : 3972 3981.
96. Huang, M.E., Ye, Y.C., Chen, S.R., Chai, J.R., Lu, J.X., Zhoa, L., Gu, L.J. Wang, Z.Y. (1988) Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood 72 : 567 572.
97. Huynh, C.K., Brodie, A.M. Njar, V.C. (2006) Inhibitory effects of retinoic acid metabolism blocking agents (RAMBAs) on the growth of human prostate cancer cells and LNCaP prostate tumour xenografts in SCID mice. Br J Cancer 94 : 513 523.
98. IJpenberg, A., Tan, N.S., Gelman, L., Kersten, S., Seydoux, J., Xu, J., Metzger, D., Canaple, L., Chambon, P., Wahli, W. Desvergne, B. (2004) In vivo activation of PPAR target genes by RXR homodimers. Embo J 23 : 2083 2091.
99. Jeronimo, C., Costa, I., Martins, M.C., Monteiro, P., Lisboa, S., Palmeira, C., Henrique, R., Teixeira, M.R. Lopes, C. (2003) Detection of gene promoter hypermethylation in fine needle washings from breast lesions. Clin Cancer Res 9 : 3413 3417.
100. Jeronimo, C., Henrique, R., Hoque, M.O., Ribeiro, F.R., Oliveira, J., Fonseca, D., Teixeira, M.R., Lopes, C. Sidransky, D. (2004) Quantitative RARbeta2 hypermethylation: a promising prostate cancer marker. Clin Cancer Res 10 : 4010 4014.
101. Johnson, D.G. Walker, C.L. (1999) Cyclins and cell cycle checkpoints. Annu Rev Pharmacol Toxicol 39 : 295 312.
102. Kato, Y., Salumbides, B.C., Wang, X.F., Qian, D.Z., Williams, S., Wei, Y., Sanni, T.B., Atadja, P. Pili, R. (2007) Antitumor effect of the histone deacetylase inhibitor LAQ824 in combination with 13-cis-retinoic acid in human malignant melanoma. Mol Cancer Ther 6 : 70 81.
103. Kawaguchi, R., Yu, J., Honda, J., Hu, J., Whitelegge, J., Ping, P., Wiita, P., Bok, D. Sun, H. (2007) A membrane receptor for retinol binding protein mediates cellular uptake of vitamin A. Science 315 : 820 825.
104. Khuri, F.R., Lee, J.J., Lippman, S.M., Kim, E.S., Cooper, J.S., Benner, S.E., Winn, R., Pajak, T.F., Williams, B., Shenouda, G., Hodson, I., Fu, K., Shin, D.M., Vokes, E.E., Feng, L., Goepfert, H. Hong, W.K. (2006) Randomized phase III trial of low-dose isotretinoin for prevention of second primary tumors in stage I and II head and neck cancer patients. J Natl Cancer Inst 98 : 441 450.
105. Kim, H., Lapointe, J., Kaygusuz, G., Ong, D.E., Li, C., van de Rijn, M., Brooks, J.D. Pollack, J.R. (2005) The retinoic acid synthesis gene ALDH1a2 is a candidate tumor suppressor in prostate cancer. Cancer Res 65 : 8118 8124.
106. Klein, E.S., Wang, J.W., Khalifa, B., Gavigan, S.A. Chandraratna, R.A. (2000) Recruitment of nuclear receptor corepressor and coactivator to the retinoic acid receptor by retinoid ligands. Influence of DNA-heterodimer interactions. J Biol Chem 275 : 19401 19408.
107. Krust, A., Kastner, P., Petkovich, M., Zelent, A. Chambon, P. (1989) A third human retinoic acid receptor, hRAR-gamma. Proc Natl Acad Sci USA 86 : 5310 5314.
108. Kuendgen, A., Schmid, M., Schlenk, R., Knipp, S., Hildebrandt, B., Steidl, C., Germing, U., Haas, R., Dohner, H. Gattermann, N. (2006) The histone deacetylase (HDAC) inhibitor valproic acid as monotherapy or in combination with all-trans retinoic acid in patients with acute myeloid leukemia. Cancer 106 : 112 119.
109. Kupumbati, T.S., Cattoretti, G., Marzan, C., Farias, E.F., Taneja, R. Mira-y-Lopez, R. (2006) Dominant negative retinoic acid receptor initiates tumor formation in mice. Mol Cancer 5 : 12.
110. Kurie, J.M., Lee, J.S., Griffin, T., Lippman, S.M., Drum, P., Thomas, M.P., Weber, C., Bader, M., Massimini, G. Hong, W.K. (1996) Phase I trial of 9-cis retinoic acid in adults with solid tumors. Clin Cancer Res 2 : 287 293.
111. Kurie, J.M., Lotan, R., Lee, J.J., Lee, J.S., Morice, R.C., Liu, D.D., Xu, X.C., Khuri, F.R., Ro, J.Y., Hittelman, W.N., Walsh, G.L., Roth, J.A., Minna, J.D. Hong, W.K. (2003) Treatment of former smokers with 9-cis-retinoic acid reverses loss of retinoic acid receptor-beta expression in the bronchial epithelium: results from a randomized placebo-controlled trial. J Natl Cancer Inst 95 : 206 214.
112. Kwok, C., Zeisig, B.B., Dong, S. So, C.W. (2006) Forced homo-oligomerization of RARalpha leads to transformation of primary hematopoietic cells. Cancer Cell 9 : 95 108.
113. Langenfeld, J., Kiyokawa, H., Sekula, D., Boyle, J. Dmitrovsky, E. (1997) Posttranslational regulation of cyclin D1 by retinoic acid: a chemoprevention mechanism. Proc Natl Acad Sci USA 94 : 12070 12074.
114. Lasnitzki, I. (1955) The influence of hypervitaminosis of the effect of 20-methylcholanthrene on mouse prostate glands growth in vitro. Br J Cancer 9 : 434 441.
115. Le, Q., Dawson, M.I., Soprano, D.R. Soprano, K.J. (2000) Modulation of retinoic acid receptor function alters the growth inhibitory response of oral SCC cells to retinoids. Oncogene 19 : 1457 1465.
116. Lee, S. Privalsky, M.L. (2005) Heterodimers of retinoic acid receptors and thyroid hormone receptors display unique combinatorial regulatory properties. Mol Endocrinol 19 : 863 878.
117. Lefebvre, B., Brand, C., Flajollet, S. Lefebvre, P. (2006) Down-regulation of the tumor suppressor gene retinoic acid receptor beta2 through the phosphoinositide 3-kinase/Akt signaling pathway. Mol Endocrinol 20 : 2109 2121.
118. Leo, C., Yang, X., Liu, J., Li, H. Chen, J.D. (2001) Role of retinoid receptor coactivator pockets in cofactor recruitment and transcriptional regulation. J Biol Chem 276 : 23127 23134.
119. Li, R., Faria, T.N., Boehm, M., Nabel, E.G. Gudas, L.J. (2004) Retinoic acid causes cell growth arrest and an increase in p27 in F9 wild type but not in F9 retinoic acid receptor beta2 knockout cells. Exp Cell Res 294 : 290 300.
120. Li, R., Saito, T., Tanaka, R., Satohisa, S., Adachi, K., Horie, M., Akashi, Y., Kudo, R., Gutierrez, P., Schnapper, L. Fontana, J.A. (2005) Hypermethylation in promoter region of retinoic acid receptor-beta gene and immunohistochemical findings on retinoic acid receptors in carcinogenesis of endometrium. Cancer Lett 219 : 33 40.
121. Li, X.S., Shao, Z.M., Sheikh, M.S., Eiseman, J.L., Sentz, D., Jetten, A.M., Chen, J.C., Dawson, M.I., Aisner, S., Rishi, A.K., Gutierrez, P., Schnapper, L. Fontana, J.A. (1995) Retinoic acid nuclear receptor beta inhibits breast carcinoma anchorage independent growth. J Cell Physiol 165 : 449 458.
122. Li, Y., Glozak, M.A., Smith, S.M. Rogers, M.B. (1999) The expression and activity of D-type cyclins in F9 embryonal carcinoma cells: modulation of growth by RXR-selective retinoids. Exp Cell Res 253 : 372 384.
123. Liang, Z.D., Lippman, S.M., Wu, T.T., Lotan, R. Xu, X.C. (2006) RRIG1 mediates effects of retinoic acid receptor beta2 on tumor cell growth and gene expression through binding to and inhibition of RhoA. Cancer Res 66 : 7111 7118.
124. Lin, B., Chen, G.Q., Xiao, D., Kolluri, S.K., Cao, X., Su, H. Zhang, X.K. (2000) Orphan receptor COUP-TF is required for induction of retinoic acid receptor beta, growth inhibition, and apoptosis by retinoic acid in cancer cells. Mol Cell Biol 20 : 957 970.
125. Lin, R.J. Evans, R.M. (2000) Acquisition of oncogenic potential by RAR chimeras in acute promyelocytic leukemia through formation of homodimers. Mol Cell 5 : 821 830.
126. Lippman, S.M., Lee, J.J., Karp, D.D., Vokes, E.E., Benner, S.E., Goodman, G.E., Khuri, F.R., Marks, R., Winn, R.J., Fry, W., Graziano, S.L., Gandara, D.R., Okawara, G., Woodhouse, C.L., Williams, B., Perez, C., Kim, H.W., Lotan, R., Roth, J.A. Hong, W.K. (2001) Randomized phase III intergroup trial of isotretinoin to prevent second primary tumors in stage I non-small-cell lung cancer. J Natl Cancer Inst 93 : 605 618.
127. Lippman, S.M., Lee, J.J., Martin, J.W., El-Naggar, A.K., Xu, X., Shin, D.M., Thomas, M., Mao, L., Fritsche, H.A. Jr., Zhou, X., Papadimitrakopoulou, V., Khuri, F.R., Tran, H., Clayman, G.L., Hittelman, W.N., Hong, W.K. Lotan, R. (2006) Fenretinide activity in retinoid-resistant oral leukoplakia. Clin Cancer Res 12 : 3109 3114.
128. Lippman, S.M., Sudbo, J. Hong, W.K. (2005) Oral cancer prevention and the evolution of molecular-targeted drug development. J Clin Oncol 23 : 346 356.
129. Liu, L. Gudas, L.J. (2005) Disruption of the lecithin: retinol acyltransferase gene makes mice more susceptible to vitamin A deficiency. J Biol Chem 280 : 40226 40234.
130. Liu, M., Iavarone, A. Freedman, L.P. (1996a) Transcriptional activation of the human p21(WAF1/CIP1) gene by retinoic acid receptor. Correlation with retinoid induction of U937 cell differentiation. J Biol Chem 271 : 31723 31728.
131. Liu, Y., Lee, M.O., Wang, H.G., Li, Y., Hashimoto, Y., Klaus, M., Reed, J.C. Zhang, X. (1996b) Retinoic acid receptor β mediates the growth-inhibitory effect of retinoic acid by promoting apoptosis in human breast cancer cells. Mol Cell Biol 16 : 1138 1149.
132. Liu, Y., Lee, M.O., Wang, H.G., Li, Y., Hashimoto, Y., Klaus, M., Reed, J.C. Zhang, X. (1996c) Retinoic acid receptor beta mediates the growth-inhibitory effect of retinoic acid by promoting apoptosis in human breast cancer cells. Mol Cell Biol 16 : 1138 1149.
133. Liu, Z., Zhang, L., Ding, F., Li, J., Guo, M., Li, W., Wang, Y., Yu, Z., Zhan, Q., Wu, M. Liu, Z. (2005) 5-Aza-2′-deoxycytidine induces retinoic acid receptor-beta(2) demethylation and growth inhibition in esophageal squamous carcinoma cells. Cancer Lett 230 : 271 283.
134. Lonard, D.M. O'Malley, B.W. (2006) The expanding cosmos of nuclear receptor coactivators. Cell 125 : 411 414.
135. Lu, N.Z., Wardell, S.E., Burnstein, K.L., Defranco, D., Fuller, P.J., Giguere, V., Hochberg, R.B., McKay, L., Renoir, J.M., Weigel, N.L., Wilson, E.M., McDonnell, D.P. Cidlowski, J.A. (2006) International Union of Pharmacology. LXV. The pharmacology and classification of the nuclear receptor superfamily: glucocorticoid, mineralocorticoid, progesterone, and androgen receptors. Pharmacol Rev 58 : 782 797.
136. Ma, Y., Feng, Q., Sekula, D., Diehl, J.A., Freemantle, S.J. Dmitrovsky, E. (2005) Retinoid targeting of different D-type cyclins through distinct chemopreventive mechanisms. Cancer Res 65 : 6476 6483.
137. Mangelsdorf, D.J., Borgmeyer, U., Heyman, R.A., Zhou, J.Y., Ong, E.S., Oro, A.E., Kakizuka, A. Evans, R.M. (1992) Characterization of three RXR genes that mediate the action of 9-cis retinoic acid. Genes Dev 6 : 329 344.
138. Mark, M., Ghyselinck, N.B. Chambon, P. (2006) Function of retinoid nuclear receptors: lessons from genetic and pharmacological dissections of the retinoic acid signaling pathway during mouse embryogenesis. Annu Rev Pharmacol Toxicol 46 : 451 480.
139. Michalik, L., Auwerx, J., Berger, J.P., Chatterjee, V.K., Glass, C.K., Gonzalez, F.J., Grimaldi, P.A., Kadowaki, T., Lazar, M.A., O'Rahilly, S., Palmer, C.N., Plutzky, J., Reddy, J.K., Spiegelman, B.M., Staels, B. Wahli, W. (2006) International Union of Pharmacology. LXI. Peroxisome proliferator- activated receptors. Pharmacol Rev 58 : 726 741.
140. Miller, W.H. Jr. (1998) The emerging role of retinoids and retinoic acid metabolism blocking agents in the treatment of cancer. Cancer 83 : 1471 1482.
141. Mira, Y.L.R., Zheng, W.L., Kuppumbatti, Y.S., Rexer, B., Jing, Y. Ong, D.E. (2000) Retinol conversion to retinoic acid is impaired in breast cancer cell lines relative to normal cells. J Cellular Physiol 185 : 302 309.
142. Mongan, N.P. Gudas, L.J. (2005) Valproic acid, in combination with all-trans retinoic acid and 5-aza-2′-deoxycytidine, restores expression of silenced RARbeta2 in breast cancer cells. Mol Cancer Ther 4 : 477 486.
143. Moore, D.D., Kato, S., Xie, W., Mangelsdorf, D.J., Schmidt, D.R., Xiao, R. Kliewer, S.A. (2006) International union of pharmacology. LXII. The NR1H and NR1I receptors: constitutive androstane receptor, pregnene X receptor, farnesoid X receptor alpha, farnesoid X receptor beta, liver X receptor alpha, liver X receptor beta, and vitamin D receptor. Pharmacol Rev 58 : 742 759.
144. Muindi, J., Frankel, S.R., Miller, W.H. Jr., Jakubowski, A., Scheinberg, D.A., Young, C.W., Dmitrovsky, E. Warrell, R.P. Jr. (1992) Continuous treatment with all-trans retinoic acid causes a progressive reduction in plasma drug
145. Mummery, C.L., van den Brink, C.E., van der Saag, P.T. de Laat, S.W. (1984) The cell cycle, cell death, and cell morphology during retinoic acid-induced differentiation of embryonal carcinoma cells. Dev Biol 104 : 297 307.
146. Nadauld, L.D., Chidester, S., Shelton, D.N., Rai, K., Broadbent, T., Sandoval, I.T., Peterson, P.W., Manos, E.J., Ireland, C.M., Yost, H.J. Jones, D.A. (2006a) Dual roles for adenomatous polyposis coli in regulating retinoic acid biosynthesis and Wnt during ocular development. Proc Natl Acad Sci USA 103 : 13409 13414.
147. Nadauld, L.D., Phelps, R., Moore, B.C., Eisinger, A., Sandoval, I.T., Chidester, S., Peterson, P.W., Manos, E.J., Sklow, B., Burt, R.W. Jones, D.A. (2006b) Adenomatous polyposis coli control of C-terminal binding protein-1 stability regulates expression of intestinal retinol dehydrogenases. J Biol Chem 281 : 37828 37835.
148. Nadauld, L.D., Sandoval, I.T., Chidester, S., Yost, H.J. Jones, D.A. (2004) Adenomatous polyposis coli control of retinoic acid biosynthesis is critical for zebrafish intestinal development and differentiation. J Biol Chem 279 : 51581 51589.
149. Nadauld, L.D., Shelton, D.N., Chidester, S., Yost, H.J. Jones, D.A. (2005) The zebrafish retinol dehydrogenase, rdh1l, is essential for intestinal development and is regulated by the tumor suppressor adenomatous polyposis coli. J Biol Chem 280 : 30490 30495.
150. Naderi, S. Blomhoff, H.K. (1999) Retinoic acid prevents phosphorylation of pRB in normal human B lymphocytes: regulation of cyclin E, cyclin A, and p21(Cip1). Blood 94 : 1348 1358.
151. Nagy, L., Kao, H.Y., Chakravarti, D., Lin, R.J., Hassig, C.A., Ayer, D.E., Schreiber, S.L. Evans, R.M. (1997) Nuclear receptor repression mediated by a complex containing SMRT, mSin3A, and histone deacetylase. Cell 89 : 373 380.
152. Naka, K., Yokozaki, H., Domen, T., Hayashi, K., Kuniyasu, H., Yasui, W., Lotan, R. Tahara, E. (1997) Growth inhibition of cultured human gastric cancer cells by 9-cis-retinoic acid with induction of cdk inhibitor Waf1/Cip1/Sdi1/p21 protein. Differentiation 61 : 313 320.
153. Nakamura, M., Matsuo, T., Stauffer, J., Neckers, L. Thiele, C.J. (2003) Retinoic acid decreases targeting of p27 for degradation via an N-myc-dependent decrease in p27 phosphorylation and an N-myc-independent decrease in Skp2. Cell Death Differ 10 : 230 239.
154. Nakayama, T., Watanabe, M., Yamanaka, M., Hirokawa, Y., Suzuki, H., Ito, H., Yatani, R. Shiraishi, T. (2001) The role of epigenetic modifications in retinoic acid receptor beta2 gene expression in human prostate cancers. Lab Invest 81 : 1049 1057.
155. Niles, R.M. (2004) Signaling pathways in retinoid chemoprevention and treatment of cancer. Mutat Res 555 : 81 96.
156. O'Brien, C.A., Pollett, A., Gallinger, S. Dick, J.E. (2007) A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 445 : 106 110.
157. O'Byrne, S.M., Wongsiriroj, N., Libien, J., Vogel, S., Goldberg, I.J., Baehr, W., Palczewski, K. Blaner, W.S. (2005) Retinoid absorption and storage is impaired in mice lacking lecithin: retinol acyltransferase (LRAT). J Biol Chem 280 : 35647 35657.
158. Ohnuma-Ishikawa, K., Morio, T., Yamada, T., Sugawara, Y., Ono, M., Nagasawa, M., Yasuda, A., Morimoto, C., Ohnuma, K., Dang, N.H., Hosoi, H., Verdin, E. Mizutani, S. (2007) Knockdown of XAB2 enhances all-trans retinoic acid-induced cellular differentiation in all-trans retinoic acid-sensitive and -resistant cancer cells. Cancer Res 67 : 1019 1029.
159. Ottonello, S., Petrucco, S. Maraini, G. (1987) Vitamin A uptake from retinol-binding protein in a cell-free system from pigment epithelial cells of bovine retina. Retinol transfer from plasma retinol-binding protein to cytoplasmic retinol-binding protein with retinyl-ester formation as the intermediate step. J Biol Chem 262 : 3975 3981.
160. Park, D.M., Li, J., Okamoto, H., Akeju, O., Kim, S.H., Lubensky, I., Vortmeyer, A., Dambrosia, J., Weil, R.J., Oldfield, E.H., Park, J.K. Zhuang, Z. (2007) N-CoR pathway targeting induces glioblastoma derived cancer stem cell differentiation. Cell Cycle 6 : 467 470.
161. Pasquali, D., Thaller, C. Eichele, G. (1996) Abnormal level of retinoic acid in prostate cancer tissues. J Clin Endocrinol Metab 81 : 2186 2191.
162. Pasutto, F., Sticht, H., Hammersen, G., Gillessen-Kaesbach, G., Fitzpatrick, D.R., Nurnberg, G., Brasch, F., Schirmer-Zimmermann, H., Tolmie, J.L., Chitayat, D., Houge, G., Fernandez-Martinez, L., Keating, S., Mortier, G., Hennekam, R.C., von der Wense, A., Slavotinek, A., Meinecke, P., Bitoun, P., Becker, C., Nurnberg, P., Reis, A. Rauch, A. (2007) Mutations in STRA6 cause a broad spectrum of malformations including anophthalmia, congenital heart defects, diaphragmatic hernia, alveolar capillary dysplasia, lung hypoplasia, and mental retardation. Am J Hum Genet 80 : 550 560.
163. Perissi, V., Staszewski, L.M., McInerney, E.M., Kurokawa, R., Krones, A., Rose, D.W., Lambert, M.H., Milburn, M.V., Glass, C.K. Rosenfeld, M.G. (1999) Molecular determinants of nuclear receptor-corepressor interaction. Genes Dev 13 : 3198 3208.
164. Petkovich, M., Brand, N.J., Krust, A. Chambon, P. (1987) A human retinoic acid receptor which belongs to the family of nuclear receptors. Nature 330 : 444 450.
165. Petty, W.J., Li, N., Biddle, A., Bounds, R., Nitkin, C., Ma, Y., Dragnev, K.H., Freemantle, S.J. Dmitrovsky, E. (2005) A novel retinoic acid receptor beta isoform and retinoid resistance in lung carcinogenesis. J Natl Cancer Inst 97 : 1645 1651.
166. Pilkington, G.J. (2005) Cancer stem cells in the mammalian central nervous system. Cell Prolif 38 : 423 433.
167. Pozzi, S., Rossetti, S., Bistulfi, G. Sacchi, N. (2006) RAR-mediated epigenetic control of the cytochrome P450 Cyp26a1 in embryocarcinoma cells. Oncogene 25 : 1400 1407.
168. Prince, M.E., Sivanandan, R., Kaczorowski, A., Wolf, G.T., Kaplan, M.J., Dalerba, P., Weissman, I.L., Clarke, M.F. Ailles, L.E. (2007) Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proc Natl Acad Sci USA 104 : 973 978.
169. Raman, J.D., Mongan, N.P., Tickoo, S.K., Boorjian, S.A., Scherr, D.S. Gudas, L.J. (2005) Increased expression of the polycomb group gene, EZH2, in transitional cell carcinoma of the bladder. Clin Cancer Res 11 : 8570 8576.
170. Recchia, F., De Filippis, S., Rosselli, M., Saggio, G., Cesta, A., Fumagalli, L. Rea, S. (2001) Phase 1B study of subcutaneously administered interleukin 2 in combination with 13-cis retinoic acid as maintenance therapy in advanced cancer. Clin Cancer Res 7 : 1251 1257.
171. Recchia, F., De Filippis, S., Rosselli, M., Saggio, G., Fumagalli, L. Rea, S. (2002) Interleukin-2 and 13-cis retinoic acid in the treatment of minimal residual disease: a phase II study. Int J Oncol 20 : 1275 1282.
172. Recchia, F., Saggio, G., Cesta, A., Alesse, E., Gallo, R., Necozione, S. Rea, S. (2005) Phase II randomized study of interleukin-2 with or without 13-cis retinoic acid as maintenance therapy in patients with advanced cancer responsive to chemotherapy. Anticancer Res 25 : 3149 3157.
173. Resendes, K.K. Rosmarin, A.G. (2006) GA-binding protein and p300 are essential components of a retinoic acid-induced enhanceosome in myeloid cells. Mol Cell Biol 26 : 3060 3070.
174. Ricci-Vitiani, L., Lombardi, D.G., Pilozzi, E., Biffoni, M., Todaro, M., Peschle, C. De Maria, R. (2007) Identification and expansion of human colon-cancer-initiating cells. Nature 445 : 111 115.
175. Robinson-Rechavi, M., Escriva Garcia, H. Laudet, V. (2003) The nuclear receptor superfamily. J Cell Sci 116 : 585 586.
176. Rosenfeld, M.G., Lunyak, V.V. Glass, C.K. (2006) Sensors and signals: a coactivator/corepressor/epigenetic code for integrating signal-dependent programs of transcriptional response. Genes Dev 20 : 1405 1428.
177. Ross, A.C. (2003) Retinoid production and catabolism: role of diet in regulating retinol esterification and retinoic acid oxidation. J Nutrit 133 : 291S 296S.
178. Ruiz, A., Winston, A., Lim, Y.H., Gilbert, B.A., Rando, R.R. Bok, D. (1999) Molecular and biochemical characterization of lecithin retinol acyltransferase. J Biol Chem 274 : 3834 3841.
179. Scaglioni, P.P. Pandolfi, P.P. (2007) The theory of APL revisited. Curr Top Microbiol Immunol 313 : 85 100.
180. Schneider, S.M., Offterdinger, M., Huber, H. Grunt, T.W. (2000) Activation of retinoic acid receptor alpha is sufficient for full induction of retinoid responses in SK-BR-3 and T47D human breast cancer cells. Cancer Res 60 : 5479 5487.
181. Seewaldt, V.L., Caldwell, L.E., Johnson, B.S., Swisshelm, K., Collins, S.J. Tsai, S. (1997a) Inhibition of retinoic acid receptor function in normal human mammary epithelial cells results in increased cellular proliferation and inhibits the formation of a polarized epithelium in vitro. Exp Cell Res 236 : 16 28.
182. Seewaldt, V.L., Dietze, E.C., Johnson, B.S., Collins, S.J. Parker, M.B. (1999a) Retinoic acid-mediated G1-S-phase arrest of normal human mammary epithelial cells is independent of the level of p53 protein expression. Cell Growth Differ 10 : 49 59.
183. Seewaldt, V.L., Johnson, B.S., Parker, M.B., Collins, S.J. Swisshelm, K. (1995) Expression of retinoic acid receptor beta mediates retinoic acid-induced growth arrest and apoptosis in breast cancer cells. Cell Growth Differ 6 : 1077 1088.
184. Seewaldt, V.L., Kim, J.H., Caldwell, L.E., Johnson, B.S., Swisshelm, K. Collins, S.J. (1997b) All-trans-retinoic acid mediates G1 arrest but not apoptosis of normal human mammary epithelial cells. Cell Growth Differ 8 : 631 641.
185. Seewaldt, V.L., Kim, J.H., Parker, M.B., Dietze, E.C., Srinivasan, K.V. Caldwell, L.E. (1999b) Dysregulated expression of cyclin D1 in normal human mammary epithelial cells inhibits all-trans-retinoic acid-mediated G0/G1-phase arrest and differentiation in vitro. Exp Cell Res 249 : 70 85.
186. Sheaff, R.J., Groudine, M., Gordon, M., Roberts, J.M. Clurman, B.E. (1997) Cyclin E-CDK2 is a regulator of p27Kip1. Genes Dev 11 : 1464 1478.
187. Shelton, D.N., Sandoval, I.T., Eisinger, A., Chidester, S., Ratnayake, A., Ireland, C.M. Jones, D.A. (2006) Up-regulation of CYP26A1 in adenomatous polyposis coli-deficient vertebrates via a WNT-dependent mechanism: implications for intestinal cell differentiation and colon tumor development. Cancer Res 66 : 7571 7577.
188. Sheren-Manoff, M., Shin, S.J., Su, D., Bok, D., Rando, R.R. Gudas, L.J. (2006) Reduced lecithin: retinol acyltransferase expression in human breast cancer. Int J Oncol 29 : 1193 1199.
189. Shimizu, M., Suzui, M., Deguchi, A., Lim, J.T. Weinstein, I.B. (2004) Effects of acyclic retinoid on growth, cell cycle control, epidermal growth factor receptor signaling, and gene expression in human squamous cell carcinoma cells. Clin Cancer Res 10 : 1130 1140.
190. Shin, D.M., Glisson, B.S., Khuri, F.R., Clifford, J.L., Clayman, G., Benner, S.E., Forastiere, A.A., Ginsberg, L., Liu, D., Lee, J.J., Myers, J., Goepfert, H., Lotan, R., Hong, W.K. Lippman, S.M. (2002) Phase II and biologic study of interferon alfa, retinoic acid, and cisplatin in advanced squamous skin cancer. J Clin Oncol 20 : 364 370.
191. Singletary, S.E., Atkinson, E.N., Hoque, A., Sneige, N., Sahin, A.A., Fritsche, H.A., Jr, Lotan, R., Lu, T., Hittelman, W.N., Bevers, T.B., Stelling, C.B. Lippman, S.M. (2002) Phase II clinical trial of N-(4-hydroxyphenyl) retinamide and tamoxifen administration before definitive surgery for breast neoplasia. Clin Cancer Res 8 : 2835 2842.
192. Sirchia, S.M., Ferguson, A.T., Sironi, E., Subramanyan, S., Orlandi, R., Sukumar, S. Sacchi, N. (2000) Evidence of epigenetic changes affecting the chromatin state of the retinoic acid receptor beta2 promoter in breast cancer cells. Oncogene 19 : 1556 1563.
193. Sirchia, S.M., Ren, M., Pili, R., Sironi, E., Somenzi, G., Ghidoni, R., Toma, S., Nicolo, G. Sacchi, N. (2002) Endogenous reactivation of the RARbeta2 tumor suppressor gene epigenetically silenced in breast cancer. Cancer Res 62 : 2455 2461.
194. Sohn, Y.C., Kim, S.W., Lee, S., Kong, Y.Y., Na, D.S., Lee, S.K. Lee, J.W. (2003) Dynamic inhibition of nuclear receptor activation by corepressor binding. Mol Endocrinol 17 : 366 372.
195. Song, S., Lippman, S.M., Zou, Y., Ye, X., Ajani, J.A. Xu, X.C. (2005) Induction of cyclooxygenase-2 by benzo[a]pyrene diol epoxide through inhibition of retinoic acid receptor-beta 2 expression. Oncogene 24 : 8268 8276.
196. Spinella, M.J., Freemantle, S.J., Sekula, D., Chang, J.H., Christie, A.J. Dmitrovsky, E. (1999) Retinoic acid promotes ubiquitination and proteolysis of cyclin D1 during induced tumor cell differentiation. J Biol Chem 274 : 22013 22018.
197. Sternsdorf, T., Phan, V.T., Maunakea, M.L., Ocampo, C.B., Sohal, J., Silletto, A., Galimi, F., Le Beau, M.M., Evans, R.M. Kogan, S.C. (2006) Forced retinoic acid receptor alpha homodimers prime mice for APL-like leukemia. Cancer Cell 9 : 81 94.
198. Subbaramaiah, K., Cole, P.A. Dannenberg, A.J. (2002) Retinoids and carnosol suppress cyclooxygenase-2 transcription by CREB-binding protein/p300-dependent and -independent mechanisms. Cancer Res 62 : 2522 2530.
199. Sueoka, N., Lee, H.Y., Walsh, G.L., Hong, W.K. Kurie, J.M. (1999) Posttranslational mechanisms contribute to the suppression of specific cyclin: CDK complexes by all-trans retinoic acid in human bronchial epithelial cells. Cancer Res 59 : 3838 3844.
200. Suh, Y.A., Lee, H.Y., Virmani, A., Wong, J., Mann, K.K., Miller, W.H., Jr, Gazdar, A. Kurie, J.M. (2002) Loss of retinoic acid receptor beta gene expression is linked to aberrant histone H3 acetylation in lung cancer cell lines. Cancer Res 62 : 3945 3949.
201. Sun, S.Y. Lotan, R. (2002) Retinoids and their receptors in cancer development and chemoprevention. Crit Rev Oncol Hematol 41 : 41 55.
202. Suzui, M., Masuda, M., Lim, J.T., Albanese, C., Pestell, R.G. Weinstein, I.B. (2002) Growth inhibition of human hepatoma cells by acyclic retinoid is associated with induction of p21(CIP1) and inhibition of expression of cyclin D1. Cancer Res 62 : 3997 4006.
203. Suzui, M., Shimizu, M., Masuda, M., Lim, J.T., Yoshimi, N. Weinstein, I.B. (2004) Acyclic retinoid activates retinoic acid receptor beta and induces transcriptional activation of p21(CIP1) in HepG2 human hepatoma cells. Mol Cancer Ther 3 : 309 316.
204. Swift, M.E., Wallden, B., Wayner, E.A. Swisshelm, K. (2006) Truncated RAR beta isoform enhances proliferation and retinoid resistance. J Cell Physiol 209 : 718 725.
205. Swisshelm, K., Ryan, K., Lee, X., Tsou, H.C., Peacocke, M. Sager, R. (1994) Down-regulation of retinoic acid receptor beta in mammary carcinoma cell lines and its up-regulation in senescing normal mammary epithelial cells. Cell Growth Differ 5 : 133 141.
206. Tashiro, E., Maruki, H., Minato, Y., Doki, Y., Weinstein, I.B. Imoto, M. (2003) Overexpression of cyclin D1 contributes to malignancy by up-regulation of fibroblast growth factor receptor 1 via the pRB/E2F pathway. Cancer Res 63 : 424 431.
207. Tighe, A.P. Talmage, D.A. (2004) Retinoids arrest breast cancer cell proliferation: retinoic acid selectively reduces the duration of receptor tyrosine kinase signaling. Exp Cell Res 301 : 147 157.
208. Touma, S.E., Goldberg, J.S., Moench, P., Guo, X., Tickoo, S.K., Gudas, L.J. Nanus, D.M. (2005) Retinoic acid and the histone deacetylase inhibitor trichostatin a inhibit the proliferation of human renal cell carcinoma in a xenograft tumor model. Clin Cancer Res 11 : 3558 3566.
209. Treutin, P.M., Chen, L.I., Buetow, B.S., Zeng, W., Birkebak, T.A., Seewaldt, V.L., Sommer, K.M., Emond, M., Maggio-Price, L. Swisshelm, K. (2002) Retinoic acid receptor beta2 inhibition of metastasis in mouse mammary gland xenografts. Breast Cancer Res Treat 72 : 79 88.
210. Tsimberidou, A.M., Tirado-Gomez, M., Andreeff, M., O'Brien, S., Kantarjian, H., Keating, M., Lopez-Berestein, G. Estey, E. (2006) Single-agent liposomal all-trans retinoic acid can cure some patients with untreated acute promyelocytic leukemia: an update of The University of Texas M. D. Anderson Cancer Center Ser Leuk Lymphoma 47 : 1062 1068.
211. van der Burg, B., van der Leede, B.M., Kwakkenbos-Isbrucker, L., Salverda, S., de Laat, S.W. van der Saag, P.T. (1993) Retinoic acid resistance of estradiol-independent breast cancer cells coincides with diminished retinoic acid receptor function. Mol Cell Endocrinol 91 : 149 157.
212. Verma, A.K. (2003) Retinoids in chemoprevention of cancer. J Biol Regul Homeost Agents 17 : 92 97.
213. Villa, R., De Santis, F., Gutierrez, A., Minucci, S., Pelicci, P.G. Di Croce, L. (2004) Epigenetic gene silencing in acute promyelocytic leukemia. Biochem Pharmacol 68 : 1247 1254.
214. Villa, R., Morey, L., Raker, V.A., Buschbeck, M., Gutierrez, A., De Santis, F., Corsaro, M., Varas, F., Bossi, D., Minucci, S., Pelicci, P.G. Di Croce, L. (2006) The methyl-CpG binding protein MBD1 is required for PML-RARalpha function. Proc Natl Acad Sci USA 103 : 1400 1405.
215. Wan, H., Oridate, N., Lotan, D., Hong, W.K. Lotan, R. (1999) Overexpression of retinoic acid receptor beta in head and neck squamous cell carcinoma cells increases their sensitivity to retinoid-induced suppression of squamous differentiation by retinoids. Cancer Res 59 : 3518 3526.
216. Wang, J., Barsky, L.W., Shum, C.H., Jong, A., Weinberg, K.I., Collins, S.J., Triche, T.J. Wu, L. (2002) Retinoid-induced G1 arrest and differentiation activation are associated with a switch to cyclin-dependent kinase-activating kinase hypophosphorylation of retinoic acid receptor alpha. J Biol Chem 277 : 43369 43376.
217. Wang, J.G., Barsky, L.W., Davicioni, E., Weinberg, K.I., Triche, T.J., Zhang, X.K. Wu, L. (2006) Retinoic acid induces leukemia cell G1 arrest and transition into differentiation by inhibiting cyclin-dependent kinase-activating kinase binding and phosphorylation of PML/RARalpha. Faseb J 20 : 2142 2144.
218. Wang, X.F., Qian, D.Z., Ren, M., Kato, Y., Wei, Y., Zhang, L., Fansler, Z., Clark, D., Nakanishi, O. Pili, R. (2005) Epigenetic modulation of retinoic acid receptor beta2 by the histone deacetylase inhibitor MS-275 in human renal cell carcinoma. Clin Cancer Res 11 : 3535 3542.
219. Warrell, R. Jr., Frankel, S., Miller, W., Scheinberg, D., Itri, L., Hittelman, W., Vyas, R., Andreef, M., Tafuri, A., Jakubowski, A., Gabrilove, J., Gordon, M.S. Dmitrovsky, E. (1991) Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans retinoic acid). New Engl J Med 324 : 1385 1393.
220. Warrell, R.P. Jr., He, L.Z., Richon, V., Calleja, E. Pandolfi, P.P. (1998) Therapeutic targeting of transcription in acute promyelocytic leukemia by use of an inhibitor of histone deacetylase. J Natl Cancer Inst 90 : 1621 1625.
221. Westin, S., Kurokawa, R., Nolte, R.T., Wisely, G.B., McInerney, E.M., Rose, D.W., Milburn, M.V., Rosenfeld, M.G. Glass, C.K. (1998) Interactions controlling the assembly of nuclear-receptor heterodimers and co-activators. Nature 395 : 199 202.
222. Widschwendter, M., Berger, J., Daxenbichler, G., Muller-Holzner, E., Widschwendter, A., Mayr, A., Marth, C. Zeimet, A.G. (1997) Loss of retinoic acid receptor beta expression in breast cancer and morphologically normal adjacent tissue but not in the normal breast tissue distant from the cancer. Cancer Res 57 : 4158 4161.
223. Wisman, G.B., Nijhuis, E.R., Hoque, M.O., Reesink-Peters, N., Koning, A.J., Volders, H.H., Buikema, H.J., Boezen, H.M., Hollema, H., Schuuring, E., Sidransky, D. van der Zee, A.G. (2006) Assessment of gene promoter hypermethylation for detection of cervical neoplasia. Int J Cancer 119 : 1908 1914.
224. Wolbach, S.B. Howe, P.R. (1925) Tissue changes following deprivation of fat soluble vitamin A. J Expt Med 42 : 752 777.
225. Wu, K., Zhang, Y., Xu, X.C., Hill, J., Celestino, J., Kim, H.T., Mohsin, S.K., Hilsenbeck, S.G., Lamph, W.W., Bissonette, R. Brown, P.H. (2002) The retinoid X receptor-selective retinoid, LGD1069, prevents the development of estrogen receptor-negative mammary tumors in transgenic mice. Cancer Res 62 : 6376 6380.
226. Xiao, S., Li, D., Zhu, H.Q., Song, M.G., Pan, X.R., Jia, P.M., Peng, L.L., Dou, A.X., Chen, G.Q., Chen, S.J., Chen, Z. Tong, J.H. (2006) RIG-G as a key mediator of the antiproliferative activity of interferon-related pathways through enhancing p21 and p27 proteins. Proc Natl Acad Sci USA 103 : 16448 16453.
227. Xu, H., Cheepala, S., McCauley, E., Coombes, K., Xiao, L., Fischer, S.M. Clifford, J.L. (2006) Chemoprevention of skin carcinogenesis by phenylretinamides: retinoid receptor-independent tumor suppression. Clin Cancer Res 12 : 969 979.
228. Xu, X.C., Ro, J.Y., Lee, J.S., Shin, D.M., Hong, W.K. Lotan, R. (1994) Differential expression of nuclear retinoid receptors in normal, premalignant, and malignant head and neck tissues. Cancer Res 54 : 3580 3587.
229. Xu, X.C., Sneige, N., Liu, X., Nandagiri, R., Lee, J.J., Lukmanji, F., Hortobagyi, G., Lippman, S.M., Dhingra, K. Lotan, R. (1997) Progressive decrease in nuclear retinoic acid receptor β messenger RNA level during breast carcinogenesis. Cancer Res 57 : 4992 4996.
230. Yang, Q., Mori, I., Shan, L., Nakamura, M., Nakamura, Y., Utsunomiya, H., Yoshimura, G., Suzuma, T., Tamaki, T., Umemura, T., Sakurai, T. Kakudo, K. (2001) Biallelic inactivation of retinoic acid receptor beta2 gene by epigenetic change in breast cancer. Am J Pathol 158 : 299 303.
231. Yao, T.P., Ku, G., Zhou, N., Scully, R. Livingston, D.M. (1996) The nuclear hormone receptor coactivator SRC-1 is a specific target of p300. Proc Natl Acad Sci USA 93 : 10626 10631.
232. Yasmin, R., Yeung, K.T., Chung, R.H., Gaczynska, M.E., Osmulski, P.A. Noy, N. (2004) DNA-looping by RXR tetramers permits transcriptional regulation "at a distance." J Mol Biol 343 : 327 338.
233. Yen, A., Roberson, M.S., Varvayanis, S. Lee, A.T. (1998) Retinoic acid induced mitogen-activated protein (MAP)/extracellular signal-regulated kinase (ERK) kinase-dependent MAP kinase activation needed to elicit HL-60 cell differentiation and growth arrest. Cancer Res 58 : 3163 3172.
234. Yin, S., Li, J., Hu, C., Chen, X., Yao, M., Yan, M., Jiang, G., Ge, C., Xie, H., Wan, D., Yang, S., Zheng, S. Gu, J. (2007) CD133 positive hepatocellular carcinoma cells possess high capacity for tumorigenicity. Int J Cancer 120 : 1436 1442.
235. Yin, W., Rossin, A., Clifford, J.L. Gronemeyer, H. (2006) Co-resistance to retinoic acid and TRAIL by insertion mutagenesis into RAM. Oncogene 25 : 3735 3744.
236. Youssef, E.M., Lotan, D., Issa, J.P., Wakasa, K., Fan, Y.H., Mao, L., Hassan, K., Feng, L., Lee, J.J., Lippman, S.M., Hong, W.K. Lotan, R. (2004) Hypermethylation of the retinoic acid receptor-beta(2) gene in head and neck carcinogenesis. Clin Cancer Res 10 : 1733 1742.
237. Zancai, P., Cariati, R., Rizzo, S., Boiocchi, M. Dolcetti, R. (1998) Retinoic acid-mediated growth arrest of EBV-immortalized B lymphocytes is associated with multiple changes in G1 regulatory proteins: p27Kip1 up-regulation is a relevant early event. Oncogene 17 : 1827 1836.
238. Zancai, P., Dal Col, J., Piccinin, S., Guidoboni, M., Cariati, R., Rizzo, S., Boiocchi, M., Maestro, R. Dolcetti, R. (2005) Retinoic acid stabilizes p27Kip1 in EBV-immortalized lymphoblastoid B cell lines through enhanced proteasome-dependent degradation of the p45Skp2 and Cks1 proteins. Oncogene 24 : 2483 2494.
239. Zelent, A., Krust, A., Petkovich, M., Kastner, P. Chambon, P. (1989) Cloning of murine alpha and beta retinoic acid receptors and a novel receptor gamma predominantly expressed in skin. Nature 339 : 714 717.
240. Zhan, H.C., Gudas, L.J., Bok, D., Rando, R., Nanus, D.M. Tickoo, S.K. (2003a) Differential expression of the enzyme that esterifies retinol, lecithin: retinol acyltransferase, in subtypes of human renal cancer and normal kidney. Clin Cancer Res 9 : 4897 4905.
241. Zhan, H.C., Gudas, L.J., Bok, D., Rando, R.R., Nanus, D.M. Tickoo, S.K. (2003b) Differential expression of the enzyme that esterifies retinol, lecitihin: retinol acyltransferase, in subtypes of human renal cancer and normal kidney. Clinical Cancer Research 9 : 4897 4905.
242. Zhang, C. Duvic, M. (2006) Treatment of cutaneous T-cell lymphoma with retinoids. Dermatol Ther 19 : 264 271.
243. Zhang, Z., Joh, K., Yatsuki, H., Zhao, W., Soejima, H., Higashimoto, K., Noguchi, M., Yokoyama, M., Iwasaka, T. Mukai, T. (2006) Retinoic acid receptor beta2 is epigenetically silenced either by DNA methylation or repressive histone modifications at the promoter in cervical cancer cells. Cancer Lett 247 : 318 327.
244. Zhu, W.Y., Jones, C.S., Kiss, A., Matsukuma, K., Amin, S. De Luca, L.M. (1997) Retinoic acid inhibition of cell cycle progression in MCF-7 human breast cancer cells. Exp Cell Res 234 : 293 299.
245. Zhuang, Y., Faria, T.N., Chambon, P. Gudas, L.J. (2003) Identification and characterization of retinoic acid receptor beta2 target genes in F9 teratocarcinoma cells. Mol Cancer Res 1 : 619 630.